
WAY Stock Forecast & Price Target
WAY Analyst Ratings
Bulls say
Waystar Holding Corp has demonstrated a robust revenue growth trajectory, achieving a compound annual growth rate (CAGR) of 16% since 2022, with anticipated further acceleration in 2024 linked to the impacts of the Change Healthcare cyberattack. The company's provider solutions and patient payment solutions have both shown impressive year-over-year growth, with provider solutions increasing by 17% and patient payment solutions by 27% in 2024. Additionally, while channel partner fees, which constitute a significant portion of sales and marketing expenses, have risen from 6.5% of revenue in 2022 to 7.1% in the first half of 2025, this increase reflects the company's strategic investment in expanding its partnerships to bolster overall revenue growth.
Bears say
Waystar Holding Corp is facing a negative financial outlook primarily due to declining revenue projections, with management anticipating a sequential decrease in 3Q revenue and flat performance in 4Q compared to 3Q. Additionally, the company's Net Revenue Retention (NRR) is declining, dropping from 114% to approximately 110-111% when excluding the recent influx of Change clients, indicating potential challenges in sustaining existing customer relationships. Furthermore, the company's EBITDA has significantly decreased from 6.4x at the end of 2023 to only 2.2x at the end of 2Q, reflecting a sharp decline in profitability and operational efficiency.
This aggregate rating is based on analysts' research of Waystar Holding Corp and is not a guaranteed prediction by Public.com or investment advice.
WAY Analyst Forecast & Price Prediction
Start investing in WAY
Order type
Buy in
Order amount
Est. shares
0 shares